Revitas to Present Best Practices for Data Validation at ACI Chargebacks and Commercial Rebates Conference

PHILADELPHIA--(BUSINESS WIRE)--Revitas announced today that it will present at this week’s ACI Chargebacks and Commercial Rebates Conference. According to IDC Health Insights, revenue leakage costs U.S. pharmaceutical companies an estimated $11 billion annually, and inefficient chargeback and rebate processes can add millions to that total. The conference will bring together key industry stakeholders to discuss solutions for the healthcare distribution chain.

MORE ON THIS TOPIC